About Contact Us Careers
Sign In

Preeclampsia Diagnostics Market Market - Top Companies and Manufacturers

  • Report ID: 4412
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Companies Dominating the Preeclampsia Diagnostics Landscape

    • ACON Laboratories Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bio Rad Laboratories Inc.
    • BioCheck Inc.
    • bioMerieux SA
    • Cardinal Health Inc.
    • Diabetomics Inc.
    • F. Hoffmann La Roche Ltd.
    • Thermo Fisher Inc.
    • Biora Therapeutics Inc
    • Sysmex Corporation
    • Hitachi Ltd.
    • Fujirebio Diagnostics
    • Siemens Healthineers AG
    • Fujifilm Corporation

     

Browse Key Market Insights with Data Illustration:

In the News

  • Thermo Fisher Scientific Inc., a world leader in serving science, announced in May 2023 that the U.S. Food and Drug Administration approved Thermo Scientific B·R·A·H· M·S PlGF plus KRYPTOR and B ·R·A·H . ·M·S sFlt-1 KRYPTOR novel biomarker, the first and only immunoassay to receive breakthrough designation and be validated for risk assessment and clinical management of preeclampsia, a serious complications of pregnancy.
  • Biora Therapeutics, Inc., a biotechnology company that reimagines therapy delivery, has entered into an agreement to license Avero Diagnostics' Preeclampsia Ruleout test previously carried out at Northwest Pathology Company for commercial development of the product.

Author Credits:  Radhika Pawar


  • Report ID: 4412
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of preeclampsia diagnostics is evaluated at USD 1.42 billion.

Preeclampsia Diagnostics Market size was over USD 1.38 billion in 2024 and is anticipated to exceed USD 2.08 billion by the end of 2037, witnessing over 3.2% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of pre-termed births, increasing innovative tests development will drive the market growth.

North America industry is expected to hold largest revenue share of 35% by 2037, due to increasing focus on drug delivery services and vaccine discovery and development in the region.

The major players in the market are of Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., Thermo Fisher Inc., Biora Therapeutics Inc, and others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample